Login to Your Account



Cyclacel's Fourth Round Gets $39M For Cell Cycle Inhibitors

By Nuala Moran


Wednesday, February 4, 2004
LONDON - Cyclacel Ltd. raised £21.3 million (US$39 million) in an oversubscribed fourth round of private funding, bringing its total private equity raised to date to $123 million. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription